← All stocks

AGIOS PHARMACEUTICALS, INC.

AGIO No buying or selling
CIK 0001439222 #2036 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

16 insiders · 0 transactions
6.6×

Brian Goff holds 6.6 times base salary in stock. $5.62M of shares against $846.86K in salary for 2025.

Salary from the company's own proxy. The shares are what Brian Goff last reported holding, valued at $30.48, the price Common stock was last bought or sold at on the open market here, on 4 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Goff Brian
Chief Executive Officer
184,508
$5.62M
+134.2%
FOUSE JACQUALYN A
Director
154,156
$4.70M
+9.5%
Jones Cecilia
Chief Financial Officer
54,998
$1.68M
+238.0%
Gheuens Sarah
Chief Medical Officer
54,645
$1.67M
+21.0%
Burns James William
Chief Legal Officer
49,306
$1.50M
+30.8%
Milanova Tsveta
Chief Commercial Officer
46,829
$1.43M
+253.9%
Scadden David
Director
20,419
$622.37K
+31.9%
Ho Maykin
Director
19,848
$604.97K
+33.1%
Ballal Rahul D.
Director
15,230
$464.21K
+90.6%
Smith Cynthia
Director
15,230
$464.21K
+90.6%
Owen Adams Catherine
Director
10,865
$331.17K
+449.8%
CAPELLO JEFFREY D
Director
10,865
$331.17K
+449.8%
Foster-Cheek Kaye I
Director
10,284
$313.46K
+92.3%
Viswanadhan Krishnan
Chief Strategy and Operations
10,282
$313.40K
Backstrom Jay T.
Director
1,447
$44.10K
Washburn Theodore James Jr.
Principal Accounting Officer
868
$26.46K
−47.1%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 31 Aug 2016